Wellness Index Report, an independent wellness ratings and education platform, has recognized Nefense as a leader in nasal health innovation in a new Inside the Index feature. The report examines the company's hypochlorous acid (HOCl) and xylitol-based products, which are gaining attention as drug-free alternatives to traditional over-the-counter nasal sprays.
According to the feature, consumer interest in nasal health and respiratory hygiene is rising, driven by a shift toward non-pharmaceutical approaches to infection control and wellness. Nefense's solutions are formulated under the direction of Dr. Richard Downs, DDS, and are described as doctor-recommended, ENT-approved, and family-friendly.
The article reviews emerging research on hypochlorous acid, noting its antimicrobial and anti-inflammatory properties. HOCl is naturally produced by white blood cells and has been studied for its potential in respiratory health and infection control. Nefense combines HOCl with xylitol, a sugar alcohol known for its ability to inhibit bacterial growth, to create nasal sprays that support clear breathing without medications.
Wellness Index Report, founded by Lindsay O'Neill-O’Keefe, aims to help consumers and medical providers identify evidence-informed wellness solutions through expert review, customer feedback, and scientific evaluation. The Inside the Index series highlights companies and technologies shaping the future of wellness and longevity.
The full announcement, including downloadable images and bios, is available here. For more information about Wellness Index Report, visit their website.
